BioLink Life Sciences, Inc. commercializes proprietary drugs and supplements. Our special expertise includes reformulating products to improve bioavailability, reduce side effects, and improve patient compliance. BioLink has developed several products that are currently seeking co-development partners, including: Phosveda (calcium succinate), an oral phosphate binder, MagneVal (magnesium valproate hydrate), a seizure therapy, and BioFeRx, an iron chelate to treat anemia.